Innovent Biopharmaceutical Transformation

Executives with a Proven Track Record of Success Michael Yu, Ph.D. Founder, Chairman & CEO • Ph.D. in Genetics, Chinese Academy of Sciences Inventor of Oncorine®, Co-inventor of Conbercept and TYVYTⓇ Inventor of 60+ issued patents & patent applications Authorship of 50+ SCI scientific articles & book chapters 24 years of industry experience • 1997 2001: Vice President of R&D, Calydon • 2001 - 2005: Principal Scientist, Cell Genesys 2005: Vice President of R&D, Applied Genetics • . 2006 2010: Founding President and CEO, Chengdu Kanghong Biotech 2011 to date: Founding CEO and Chairman, Innovent Biologics YongJun Liu, Ph.D. President Over 30 years of academic and biopharma experience Former Head of Research, Global R&D at Sanofi and Global Head of Research, CSO at MedImmune, AZ AstraZeneca SANOFI Ronnie Ede Chief Financial Officer Former CFO of Mindray Medical International Ltd. Responsible for Finance, Investor Relation, North America Operations, and Internal Audits Former CFO of Biosensors International Ltd. mindray BIOSENSORS INTERNATIONAL™ Min Liu Chief Commercial Officer Former member of Roche Global Oncology Franchise Leadership Team Vice President of one of two Oncology Business Units at Roche Pharma China, leading marketing & sales efforts for products in lung, GI, and hematology cancers AstraZeneca Roche Vivian Zhang Chief People Officer Responsible for Human Resources, Administration, Legal, PR, GA as well as the operations of the Chairman Office Innovent 信达生物制药 Innovent Confidential Copyright©2022 Innovent 33

View entire presentation